The Science Behind Your High
Understand cannabis chemistry while keeping human evidence, preclinical research, and product claims in their proper lanes.
Core Concepts
Understanding Cannabis Science
Cannabis contains over 400 chemical compounds that work together in unique ways.
400+ Compounds
Hundreds of reported constituents, with composition varying by sample and method
Terpenes
Aroma-related compounds whose consumer effects usually remain unproven
Cannabinoids
Active compounds that interact with your endocannabinoid system
Beyond Sativa, Indica & Hybrid
You already know about Sativa (energizing), Indica (relaxing), and Hybrid (balanced). But there's a deeper layer of understanding: the High Families —a science-based system that reveals how chemistry creates experience .
🌿 Traditional: Plant Type
Sativa, Indica, and Hybrid tell you about the plant's structure , but modern research shows these categories are poor predictors of effects .
Still useful as a starting point, but not the whole picture.
🧪 High Families: Chemistry
The High Families map strains by their chemical makeup : cannabinoid ratios (THC:CBD) and terpene profiles. This predicts effects more accurately.
More precise, science-backed predictions
How the High Families Work
1. Chemotype
THC:CBD ratio determines potency and intoxication level
2. Terpene Profile
Aroma compounds that modulate effects and create unique experiences
3. Effect Family
7 effect categories based on chemistry, not plant shape
The 7 Effect Families
High Uplift
Energizing Social High
Bright limonene energy for sunny moods and social connection
High Focus
Clear Productive High
Pinene-driven clarity for mental sharpness and productivity
High Creativity
Imaginative Playful High
Limonene and caryophyllene blend for creative flow
High Calm
Relaxed Peaceful High
Linalool and myrcene for gentle relaxation
High Rest
Sleepy Sedative High
Heavy myrcene and linalool for deep rest
High Relief
Body Comfort High
Caryophyllene and humulene for targeted relief
High Balance
Steady Even High
Balanced cannabinoid and terpene profile
Use Both Systems Together
Start with Sativa/Indica/Hybrid for the basics, then dive into the High Families to understand why each strain affects you the way it does. It's not either/or—it's layers of insight .
Nature's Aromatherapy
Terpenes: Aroma Chemistry, Graded by Evidence
Flip a card to compare what is measured with what remains unknown. Aroma is not a promised effect.
Laboratory research only
Myrcene
β-Myrcene • MER-seen
- Aroma vocabulary
- earthy · musky · herbal
- Chemical class
- Acyclic monoterpene
Controlled human evidence
Limonene
D-Limonene • LIM-oh-neen
- Aroma vocabulary
- citrus peel · lemon · orange
- Chemical class
- Cyclic monoterpene
Controlled human evidence
Alpha-Pinene
α-Pinene • AL-fuh PIE-neen
- Aroma vocabulary
- pine needle · resin · fresh herbs
- Chemical class
- Bicyclic monoterpene
Animal research only
Linalool
Linalool • lin-ah-LOOL
- Aroma vocabulary
- floral · lavender-like · sweet
- Chemical class
- Acyclic monoterpene alcohol
Laboratory research only
Beta-Caryophyllene
β-Caryophyllene • BAY-tuh carry-OFF-ill-een
- Aroma vocabulary
- black pepper · spice · wood
- Chemical class
- Bicyclic sesquiterpene
Laboratory research only
Alpha-Humulene
α-Humulene • AL-fuh HYOO-muh-leen
- Aroma vocabulary
- hops · wood · earth
- Chemical class
- Monocyclic sesquiterpene
Animal research only
Terpinolene
Terpinolene • ter-PIN-oh-leen
- Aroma vocabulary
- pine · floral · citrus
- Chemical class
- Cyclic monoterpene
Chemistry and measurement
Ocimene
Ocimene isomer mixture • OH-sih-meen
- Aroma vocabulary
- sweet herbs · green · floral
- Chemical class
- Acyclic monoterpene
Showing the 8 core profiles from our 26-profile evidence library • Click any card to flip and see more details
The Active Compounds
Cannabinoids: The Engine of Effects
These compounds interact with your endocannabinoid system to produce therapeutic and psychoactive effects.
THC
Δ9-Tetrahydrocannabinol
10-30%
Primary psychoactive cannabinoid in cannabis. THC binds strongly to CB1 receptors in the brain, producing euphoria, altered perception, and appetite stimulation. Edibles convert THC to 11-OH-THC, which is more potent and produces stronger body effects.
🔬 Clinical Evidence
THC and its metabolites bind CB1 receptors in the brain, producing euphoria and analgesia. Clinical studies (2024) show that co-inhalation of low-dose limonene (1-5mg) reduces THC-induced anxiety without diminishing therapeutic benefits. CB1 receptors are the most abundant G-protein-coupled receptor in the mammalian brain.
- • Strong CB1 receptor agonist
- • Modulates neurotransmitter release
- • High CB1 density in cortical, amygdala, and basal ganglia regions
- • Metabolized to 11-OH-THC (more potent) via first-pass metabolism
CBD
Cannabidiol
0.5-20%
Non-psychoactive cannabinoid with numerous therapeutic benefits. CBD modulates cannabinoid receptor signaling indirectly and interacts with serotonin and TRPV receptors to produce anti-anxiety, anti-inflammatory, and neuroprotective effects.
🔬 Clinical Evidence
FDA-approved drug Epidiolex (pure CBD) is used to treat severe childhood epilepsies (Dravet syndrome, Lennox-Gastaut syndrome). CBD does not produce intoxication and may counteract some THC side effects through allosteric modulation of CB1 receptors.
✅ FDA Approved
Epidiolex (for epilepsy)
- • Modulates cannabinoid receptor signaling indirectly
- • Interacts with serotonin (5-HT1A) receptors
- • Activates TRPV1 (vanilloid) receptors
- • Enhances anandamide levels (FAAH inhibition)
CBG
Cannabigerol
<1% (precursor to other cannabinoids)
The "mother" or "stem cell" cannabinoid from which THC, CBD, and CBC are synthesized. CBG is usually present in low amounts (<1%) but has powerful therapeutic properties.
🔬 Clinical Evidence
2024 human clinical trial breakthrough: 20mg CBG enhanced memory recall and reduced anxiety without impairment. Preclinical studies show CBG has antibacterial activity superior to vancomycin against MRSA in mice. Also shows neuroprotective and anti-inflammatory effects.
- • Partial agonist at CB1 and CB2 receptors
- • Enhances anandamide levels
- • α2-adrenoceptor agonist
- • Superior antibacterial activity (vs. MRSA)
CBN
Cannabinol
<1% (increases with age/oxidation)
Created when THC ages or is exposed to heat/light. CBN is about 10 times less potent at CB1 receptors than THC, producing minimal intoxication but notable sedative properties.
🔬 Clinical Evidence
Preclinical studies show CBN increases non-rapid eye movement and REM sleep in rodents. The hypnotic action may result from its metabolite 11-hydroxy-CBN rather than CBN itself. Human clinical evidence is limited; a 2023 trial protocol states that robust evidence for CBN as a sleep aid is lacking, requiring more research.
- • Weak CB1 receptor agonist (~10x less potent than THC)
- • Increases non-rapid eye movement and REM sleep
- • Metabolite 11-hydroxy-CBN may be more active
- • Formed by non-enzymatic oxidation of THC
CBC
Cannabichromene
0.05-0.3%
Non-psychoactive cannabinoid synthesized from CBGA. CBC selectively activates CB2 receptors with higher efficacy than THC, leading to strong anti-inflammatory and analgesic effects without psychotropic side-effects.
🔬 Clinical Evidence
In vitro and in vivo studies show CBC reduces nitric oxide and pro-inflammatory cytokines (iNOS, IL-1β, IL-6, TNF-α) by ~50%. Inhibits NF-κB and MAPK pathways and reduces inflammation in mouse models. Because CB2 receptors are primarily on immune cells, CBC may provide targeted relief without euphoria.
- • Selectively activates CB2 receptors (higher efficacy than THC)
- • Reduces NO and pro-inflammatory cytokines by ~50%
- • Inhibits NF-κB and MAPK pathways
- • No psychotropic effects (CB2 primarily on immune cells)
THCV
Tetrahydrocannabivarin
<1% (higher in some African strains)
A homologue of THC with a shorter side chain. THCV has minimal psychoactivity at typical doses and displays unique metabolic effects including appetite suppression and enhanced energy metabolism.
🔬 Clinical Evidence
THCV acts as a CB1 receptor antagonist, leading to appetite suppression and enhanced energy metabolism. Preclinical studies show it improves insulin sensitivity, promotes glucose uptake, restores insulin signaling, reduces lipid accumulation, and enhances mitochondrial activity in adipocytes and hepatocytes. Animal models show it suppresses appetite and prevents fatty liver disease. Preliminary human trials found THCV lowers fasting plasma glucose and improves glycaemic control, making it a promising candidate for obesity and type-2 diabetes management.
- • CB1 receptor antagonist (blocks appetite stimulation)
- • Partial CB2 agonist
- • Improves insulin sensitivity
- • Enhances glucose uptake and insulin signaling
- • Reduces lipid accumulation, enhances mitochondrial activity
The Entourage Effect
A useful hypothesis with mixed laboratory results and sparse compound-specific human evidence.
What is the Entourage Effect?
The entourage effect proposes that a mixture can act differently from an isolated compound. It should not be presented as a universal enhancement: different combinations can produce positive, negative, or no detectable interaction.
D-limonene + THC
A small randomized crossover found lower ratings on some anxiety and paranoia measures only at its highest combination; limonene alone did not differ from placebo.
20 enrolled; 12 completed the highest-dose session
Alpha-pinene + THC
A 19-person randomized crossover found alpha-pinene did not mitigate THC-related memory impairment or alter other measured acute THC effects.
Negative controlled human result
Methods & Timeline
How You Consume Matters
Click to expand each method. Different methods affect onset time, duration, intensity, and bioavailability.
Smoking (Joints, Pipes, Bongs)
Combustion of cannabis flower delivers cannabinoids rapidly through lung absorption. Traditional and most common method with fast onset and easy dose titration.
Onset
1-3 minutes
Peak
20-30 minutes
Duration
1-3 hours
Bioavailability
10-35%
Vaporizing (Flower or Concentrates)
Heats cannabis below combustion point (315-430°F) to release cannabinoids and terpenes as vapor. Avoids combustion by-products while delivering more cannabinoids.
Onset
1-3 minutes
Peak
30-60 minutes
Duration
2-4 hours
Bioavailability
30-60%
Edibles (Gummies, Baked Goods, Tinctures)
Cannabinoids absorbed through digestive system. THC is metabolized to 11-OH-THC (more potent) during first-pass metabolism in the liver, producing stronger body effects.
Onset
30-90 minutes
Peak
2-4 hours
Duration
4-8+ hours
Bioavailability
5-12%
Sublingual (Tinctures, Oils)
Cannabinoids absorbed directly through mucous membranes under the tongue, bypassing some first-pass metabolism for faster onset and better bioavailability than edibles.
Onset
15-45 minutes
Peak
90 minutes
Duration
4-6 hours
Bioavailability
20-30%
Topicals (Creams, Balms, Lotions)
Applied directly to skin for localized relief. Cannabinoids act locally on CB2 receptors in skin and muscle tissue without entering bloodstream. No psychotropic effects.
Onset
15-30 minutes
Peak
45-90 minutes
Duration
2-4 hours
Bioavailability
0% systemic
Dabbing (Concentrates)
Vaporizing high-potency cannabis concentrates (wax, shatter, rosin) at high temperatures. Delivers very high doses of cannabinoids rapidly—recommended for experienced users only.
Onset
1-5 minutes
Peak
15-30 minutes
Duration
1-3 hours
Bioavailability
50-80%
The Endocannabinoid System
Your Body & Cannabis
Understanding how cannabis works in your body.
CB1 Receptors
Found primarily in the brain and central nervous system. THC binds to these receptors to produce psychoactive effects. The most abundant G-protein-coupled receptor in the mammalian brain, highly expressed in cortical, amygdala, and basal ganglia regions.
CB2 Receptors
Located primarily on immune cells and peripheral organs. CBD and other cannabinoids interact with these for therapeutic effects without psychoactivity. Up-regulated on microglia during inflammation.
🔬 Fun Fact:
The endocannabinoid system was only discovered in the 1990s, making it one of the most recently identified physiological systems. Your body naturally produces compounds similar to cannabis (anandamide and 2-AG) that regulate mood, memory, appetite, pain, and immune response.
Finding Your Balance
Tolerance & Dosage
Understanding how tolerance develops and finding your optimal dose.
Tolerance Reset Timeline
Cannabis tolerance develops due to CB1 receptor down-regulation with chronic use. Recovery timeline based on PET imaging studies.
48-72 hours
Initial reset begins
→ Minimum break for slight sensitivity improvement
1-2 weeks
Significant tolerance reduction
→ Recommended break for noticeable reset
4 weeks
Near-baseline sensitivity
→ Full reset, CB1 receptor density returns to non-user levels
📚 Evidence:
PET imaging study found cannabis-dependent subjects had ~15% lower CB1 receptor availability than controls, but receptor density recovered after only 2 days of abstinence. After 28 days, there was no difference from non-users.
Dosage Guidelines
1-2.5mg THC
Subtle effects, functional for daytime use
Best for: Beginners, daily function, microdosing protocols
2.5-5mg THC
Mild euphoria and relaxation
Best for: Beginners, social use, gentle relief
5-10mg THC
Noticeable psychoactive effects and impairment
Best for: Intermediate users, evening use, pain relief
10-20mg+ THC
Strong effects and significant impairment
Best for: Experienced users only, high tolerance, severe symptoms
⚠️ Always start low and go slow, especially with edibles. You can take more, but you can't take less.
Common Questions
Frequently Asked Questions
Everything you need to know about cannabis science and effects.
What is the entourage effect?
The entourage effect is a hypothesis that combinations of cannabis compounds can act differently from isolated compounds. Laboratory results are mixed, and controlled human evidence for individual terpene–THC combinations remains sparse, so it is not a general proven benefit.
How do terpenes influence my high?
A terpene profile describes part of a sample's chemistry and aroma; it does not reliably predict a high. Cannabinoid dose, route, tolerance, context, batch variation, and nonterpene volatiles also matter.
Why do the same strains affect people differently?
Individual differences in endocannabinoid system, metabolism, tolerance, body chemistry, and even mood all affect how cannabis impacts you. Genetic polymorphisms in CB1 receptors, enzyme activity, and differences in body fat alter absorption and clearance.
How do the High Families relate to Sativa/Indica?
The High Families are an editorial discovery framework layered onto familiar labels. They organize reported chemistry and characteristics, but they do not guarantee an individual response.
How long does tolerance take to reset?
CB1 receptors begin to recover within 48-72 hours of abstinence. Significant tolerance reduction occurs after 1-2 weeks, and near-baseline sensitivity returns by four weeks. Periodic breaks and microdosing help maintain sensitivity.
Never Buy the
Wrong Strain Again.
Stop guessing. Start knowing. High IQ turns every purchase into personal cannabis intelligence.
Be first when High IQ hits the App Store.